Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-30

Clinical Trial Update: Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial results for Therapeutic Angiotensin-(1-7) in patients with unresectable metastatic sarcoma have results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Therapeutic Angiotensin-(1-7) (angiotensin-(1-7))

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Bone Cancer, Chondrosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2014-01-30